Exact Sciences Corp (EXAS)

31.90
NASDAQ : Health Care
Prev Close 31.90
Day Low/High 0.00 / 0.00
52 Wk Low/High 5.72 / 36.14
Avg Volume 3.07M
Exchange NASDAQ
Shares Outstanding 111.19M
Market Cap 3.54B
EPS -1.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

INVESTOR ALERT: Goldberg Law PC Announces An Investigation Of Exact Sciences Corporation

INVESTOR ALERT: Goldberg Law PC Announces An Investigation Of Exact Sciences Corporation

Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Exact Sciences Corporation ("Exact" or the "Company") (Nasdaq: EXAS).

Cook Tells Cramer: Apple to Launch $1B Tech Job Fund - Cramer's 'Mad Money' Recap (Wednesday 5/3/17)

Cook Tells Cramer: Apple to Launch $1B Tech Job Fund - Cramer's 'Mad Money' Recap (Wednesday 5/3/17)

Apple CEO says fund will boost advanced manufacturing in U.S.

Making Sense of Thursday's Flood of Biotech and Pharma Earnings Reports

Making Sense of Thursday's Flood of Biotech and Pharma Earnings Reports

A guide to keep track of all the companies reporting first quarter financial results today -- making sense of what's important and disregarding what's not.

Exact Sciences Stock Soaring on Aetna Cologuard Coverage

Exact Sciences Stock Soaring on Aetna Cologuard Coverage

Aetna now offers commercial coverage of Exact Sciences' Cologuard test.

Treehouse Foods, Arconic, Kinder Morgan, Chesapeake Energy: 'Mad Money' Lightning Round

Treehouse Foods, Arconic, Kinder Morgan, Chesapeake Energy: 'Mad Money' Lightning Round

Jim Cramer is bullish on Arconic, Treehouse Foods, Magellan Midstream Partners.

Trump's Tweet Creates Opportunity in Pharma: Cramer's 'Mad Money' Recap (Tuesday 2/7/17)

Trump's Tweet Creates Opportunity in Pharma: Cramer's 'Mad Money' Recap (Tuesday 2/7/17)

Jim Cramer says if Trump really wants to lower drug prices, he should target our trading partners.

Exact Sciences And Mayo Clinic Study Shows Promise Of New Blood-based Lung Cancer Test

Exact Sciences And Mayo Clinic Study Shows Promise Of New Blood-based Lung Cancer Test

AACR abstract highlights methylation markers capable of detecting all types of lung cancer with more than 90% sensitivity and specificity

T-Mobile, Verizon, Kellogg, Box, Best Buy : 'Mad Money' Lightning Round

T-Mobile, Verizon, Kellogg, Box, Best Buy : 'Mad Money' Lightning Round

Jim Cramer is bullish on T-Mobile, Box and Treehouse Foods. He's bearish on Verizon and Best Buy.

Don't Give Trump All the Credit for Market Gains: Cramer's 'Mad Money' Recap (Thursday 2/23/17)

Don't Give Trump All the Credit for Market Gains: Cramer's 'Mad Money' Recap (Thursday 2/23/17)

Jim Cramer knows this administration is pro-business, but Washington isn't the only place building business and market strength.

Analysts' Actions -- Discovery, First Solar, Momenta, VF Corp. and More

Analysts' Actions -- Discovery, First Solar, Momenta, VF Corp. and More

Here are Wednesday's top research calls, including downgrades for Discovery, First Solar and Momenta, and an upgrade for VF Corp.

CMS Proposes Inclusion Of Cologuard In Medicare Advantage Star Ratings

CMS Proposes Inclusion Of Cologuard In Medicare Advantage Star Ratings

Cologuard offers health plans an opportunity to increase screening & improve quality ratings

Nasdaq Separates Itself From the Rest of the Market

Nasdaq Separates Itself From the Rest of the Market

Narrowing strength becomes a concern.

Major Indices' Support Holds, But Momentum Eases

Major Indices' Support Holds, But Momentum Eases

Biotech shares have gained from takeovers in that sector.

Exact Sciences To Report $99 Million In Revenues, 150 Percent Growth For 2016

Exact Sciences To Report $99 Million In Revenues, 150 Percent Growth For 2016

- Preliminary revenues between $99.0 million and $99.5 million for 2016, a year-over-year increase of 150 percent;

Cologuard Earns Positive Review From Blue Cross Blue Shield Association

Cologuard Earns Positive Review From Blue Cross Blue Shield Association

Cologuard Covered for 70 Percent of Addressable Population

Cologuard Available To Humana Members As In-Network Colon Cancer Screening Option

Cologuard Available To Humana Members As In-Network Colon Cancer Screening Option

Members of Fifth Largest Commercial Insurer will have Access to Non-Invasive Colon Cancer Screening Test and Compliance Service

Exact Sciences Appoints Jeff Elliott Chief Financial Officer

Exact Sciences Appoints Jeff Elliott Chief Financial Officer

Respected diagnostics industry expert will help lead efforts to capitalize on market opportunity for Cologuard